Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Dec 14, 2023 $22.00 $22.00 $20.82 $21.21 1 219 611
Dec 13, 2023 $19.82 $21.37 $19.73 $21.35 1 145 478
Dec 12, 2023 $19.94 $19.94 $19.37 $19.80 684 023
Dec 11, 2023 $19.87 $20.13 $19.39 $20.02 948 207
Dec 08, 2023 $20.76 $20.94 $19.98 $20.01 743 017
Dec 07, 2023 $20.88 $21.22 $20.53 $20.89 575 203
Dec 06, 2023 $20.95 $21.15 $20.58 $20.85 578 348
Dec 05, 2023 $20.52 $20.98 $20.23 $20.82 651 664
Dec 04, 2023 $20.12 $20.84 $20.00 $20.84 617 756
Dec 01, 2023 $19.48 $20.40 $18.85 $20.39 893 740
Nov 30, 2023 $19.76 $20.16 $19.46 $19.58 613 614
Nov 29, 2023 $19.33 $19.94 $19.28 $19.48 672 789
Nov 28, 2023 $19.03 $19.31 $18.44 $19.27 732 301
Nov 27, 2023 $19.43 $19.50 $18.75 $19.11 462 012
Nov 24, 2023 $19.40 $19.85 $19.39 $19.50 250 310
Nov 22, 2023 $19.60 $19.73 $19.13 $19.43 397 209
Nov 21, 2023 $19.56 $19.75 $19.19 $19.34 628 001
Nov 20, 2023 $19.26 $19.74 $18.86 $19.72 682 998
Nov 17, 2023 $18.77 $19.42 $18.66 $19.16 908 405
Nov 16, 2023 $19.14 $19.14 $18.20 $18.58 814 366
Nov 15, 2023 $19.24 $19.88 $19.20 $19.21 752 695
Nov 14, 2023 $18.31 $19.31 $18.18 $19.29 1 314 437
Nov 13, 2023 $16.80 $17.32 $16.53 $17.31 897 193
Nov 10, 2023 $17.37 $17.40 $16.78 $17.10 979 322
Nov 09, 2023 $18.52 $18.71 $17.10 $17.24 1 212 079
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT